Genpharmasec Ltd Board Meeting on Aug 11 to Approve Q1 FY27 Results

Genpharmasec Ltd has announced that its Board of Directors will convene on August 11, 2026, to consider and approve the Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. The meeting will also address other business matters as permitted by the Chairman. Concurrently, the company has enforced a trading window closure for directors, designated persons, and connected individuals from July 01, 2026, until 48 hours post-results declaration, in compliance with SEBI's Insider Trading Regulations.